Maternal age-specific down syndrome rates by maternal race/ethnicity, Hawaii, 1986-2000

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 9, 2003, Pages 625-629

  Forrester, Mathias B ^a   Merz, Ruth D ^a  

^a Hawaii Birth Defects Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURAL FACTOR; CYTOGENETICS; DOWN SYNDROME; ETHNIC DIFFERENCE; FEMALE; FETUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MATERNAL AGE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ASIAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; DOWN SYNDROME; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAR EAST; FEMALE; HAWAII; HUMANS; INFANT, NEWBORN; MATERNAL AGE; PACIFIC ISLANDS; PHILIPPINES; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; REGISTRIES; RETROSPECTIVE STUDIES;

PIERINAE;

EID: 0141529895     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10112     Document Type: Article

References (26)

1. Bishop J, Huether CA, Torfs C, Lorey F, Deddens J. 1997. Epidemiologic study of Down Syndrome in a racially diverse California population. Am J Epidemiology 145:134-147.
2. Blessed WB, Lacoste H, Welch RA. 2001. Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients. Am J Obstet Gynecol 184:1340-1342.
3. Centers for Disease Control and Prevention. 1994. Down syndrome prevalence at birth - United States, 1983-1990. MMWR Morb Mortal Wkly Rep 43:617-622.
4. Chadefaux-Vekemans B, Coude M, Muller F, Oury JF, Chabli A, Jais J, Kamoun P. 2002. Methylenetetrahydrofolate reductase polymorphism in the etiology of Down syndrome. Pediatr Res 51:766-767.
5. Chavez GF, Cordero JF, Becerra JE. 1988. Leading major congenital malformations among minority groups in the United States, 1981-1986. Mor Mortal Wkly Rep CDC Surveill Summ 37:17-24.
6. Collins JS, Olson RL, DuPont BR, Wolff DJ, Best RG, Stevenson RE. Prevalence of aneuploidies in South Carolina in the 1990s. Genet Med 2002;4:131-135.
7. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94:387-402.
8. Ferguson-Smith MA, Yates JR. 1984. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenat Diagn 4:5-44.
9. Forrester MB, Merz RD. 1999. Prenatal diagnosis and elective termination of Down syndrome in a racially mixed population in Hawaii, 1987-1996. Prenat Diagn 19:136-141.
10. Forrester MB, Merz RD. 2002. Epidemiology of Down syndrome (trisomy 21), Hawaii, 1986-97. Teratology 65:207-212.
11. Hassold TJ, Jacobs PA. 1984. Trisomy in man. Annu Rev Genet 18:69-97.
12. Hassold TJ, Burrage LC, Chan ER, Judis LM, Schwartz S, James SJ, Jacobs PA, Thomas NS. 2001. Maternal folate polymorphisms and the etiology of human nondisjunction. Am J Hum Genet 69:434-439.
13. Hecht CA, Hook EB. 1996. Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: A proposed revised rate schedule for use in genetic and prenatal screening. Am J Med Genet 62:376-385.
14. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. 2000. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67:623-630.
15. Hoshi N, Hattori R, Hanatani K, Okuyama K, Yamada H, Kishida T, Yamada T, Sagawa T, Sumiyoshi Y, Fujimoto S. 1999. Recent trends in the prevalence of Down syndrome in Japan, 1980-1997. Am J Med Genet 84:340-345.
16. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. 1999. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495-501.
17. Krivchenia E, Huether CA, Edmonds LD, May DS, Guckenberger S. 1993. Comparative epidemiology of Down syndrome in two United States populations, 1970-1989. Am J Epidemiol 137:815-828.
18. Lau TK, Fung HY, Rogers MS, Cheung KL. 1998. Racial variation in incidence of trisomy 21: survey of 57,742 Chinese deliveries. Am J Med Genet 75:386-388.
19. Morris JK, Wald NJ, Watt HC. 1999. Fetal loss in Down syndrome pregnancies. Prenat Diagn 19;142-145.
20. Morris JK, Mutton D, Alberman E. 2002. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 9:2-6.
21. National Birth Defects Prevention Network. 2001. State Birth Defects Surveillance Programs Directory. Teratology 64:S47-S116.
22. O'Leary PO, Bower C, Murch A, Crowhurst J, Goldblatt J. 1996. The impact of antenatal screening for Down syndrome in Western Australia: 1980-1994. Aust NZ J Obstet Gynecol 36:385-388.
23. O'Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, Scott JM, Mills JL. 2002. MTRR and MTHFR polymorphism: Link to Down syndrome? Am J Med Genet 107:151-155.
24. Shaw GM, Carmichael SL, Nelson V. 2002. Congenital malformations in offspring of Vietnamese women in California, 1985-97. Teratology 65:121-124.
25. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. 1999. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 13:167-170.
26. Stuppia L, Gatta V, Gaspari AR, Antonucci I, Morizio E, Calabrese G, Palka G. 2002. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet 10:388-390.